Database

Startups

Main Industry
Biotechnology
Founded Year
2016
Unified Business No.
52463776
Status
Active
Number of Employees
0
Total Paid-in Capital
10,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.

Similar Companies

Anbogen Therapeutics, Inc.

Anbogen’s drug pipeline features two lead small‑molecule candidates: “ABT‑101,” a tyrosine kinase inhibitor targeting HER2 exon20 insertion mutations in non‑small cell lung cancer; and “ABT‑301,” an HDAC1/2/3 inhibitor designed for combination therapy wit

BIONET Therapeutics Corp.

At BIONET Therapeutics Corp., our focus is on regenerative medicinal products, Advanced tech-enabled research and development, exosomes, and gene/cell therapy.